Epilepsy Surgery Market Highlights

Epilepsy Surgery Market research report has valued the industry size at USD 1.1 billion in 2022. The Epilepsy Surgery market industry is projected to grow from USD 1.16 Billion in 2023 to USD 1.62 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 5.72% during the forecast period (2023 - 2030). 

Enter the exciting world of the Epilepsy Surgery Market, where innovation meets the pursuit of a seizure-free life. This market is primed for spectacular growth as demand for accurate, life-changing solutions surges. Epilepsy surgery is at the cutting edge of modern neurology, giving millions of people hope by providing effective treatment choices when drugs fail.

Advances in neuroimaging, minimally invasive methods, and personalised treatment programmes promise better outcomes and quality of life for epilepsy patients in the future. The Epilepsy Surgery Market gives a chance for investors and healthcare pioneers to be a part of a healthcare transition, where seizing the moment means seizing a brighter future for those suffering with epilepsy. Explore this burgeoning market and help shape the future of epilepsy care.

Segment Analysis

The global epilepsy surgery market has been divided based on procedure type and end user.

Based on procedure type, the market is segregated into resective surgery, laser interstitial thermal therapy (LITT), and others.

Based on end user, the epilepsy surgery market has been divided into hospitals & clinics, specialty centers, and others

Regional Analysis

The global epilepsy surgery market has been studied in five regions, namely, the Americas, Europe, Asia-Pacific, and the Middle East &Africa. The increasing prevalence of neurological disorders leading to extensive R&D on epilepsy treatment devices, increasing cases of brain injuries due to road accidents, and advances in robot-assisted surgery are the common factors driving the growth of the global epilepsy surgery market. According to the WHO, around 50 million people around the globe have epilepsy, making it one of the most common neurological diseases worldwide. It is also estimated that about70% of people living with epilepsy could live seizure-free with the help of proper diagnosis and treatment.

Americas dominated the global epilepsy surgery market owing to various factors, such as the availability of well-established healthcare facilities, the high prevalence of neurological disorders, and the increasing incidence of epilepsy. North America is divided into the US and Canada. With increasing investment in R&D, the production of successful epilepsy medications, and a high prevalence of epilepsy, Europe has also evolved as a prominent market for epilepsy surgery.

The Asia-Pacific region offers lucrative opportunities for players in the epilepsy surgery market, owing to the presence of a large geriatric population, governmental initiatives to improve the healthcare sector, an increase in R&D activities, and an increase in epilepsy incidence in the region. The Middle East and Africa epilepsy surgery market is segmented into major regions, namely the Middle East, Africa, and Latin America. Factors such as the increasing incidence of epilepsy, the rise in the geriatric population, and the increasing disposable income of people in the region are driving the epilepsy surgery market.

MRFR recognizes the following companies as the top key players in its epilepsy surgery market report —Stryker (US), Zimmer Biomet Holdings Inc.(US),Auris Health, Inc. (Hansen Medical, Inc.) (US), Intuitive Surgical (US),Medtronic Plc (Mazor Robotics) (Ireland), Cephalon, Inc. (US), CMR Surgical(UK), Natus Medical Incorporated(US), Livanova Plc (UK), and Monteris Medical(US).

Key Findings of the Study

  • The global epilepsy surgery market is projected to grow from USD 1.16 Billion in 2023 to USD 1.62 billion by 2030 and to register a CAGR of 5.72% during the assessment period.
  • The Americas accounted for the largest share of the global market due to the well-developed healthcare sector, rising prevalence and incidence rate of infectious diseases, and the presence of leading players.
  • Based on procedure type, resective surgery accounted for a market share of 33.9% in 2020.
  • Based on end user, the hospitals & clinics segment is expected to register the fastest growth at a CAGR of 6.56% during the forecast period.
  • The key market players are Medtronic Plc, Zimmer Biomet Holdings Inc., Stryker, Natus Medical Incorporated, and LivaNova.

About Market Research Future:

Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.

Contact Us:

Market Research Future (Part of Wantstats Research and Media Private Limited)

99 Hudson Street, 5Th Floor

New York, NY 10013

United States of America

+1 628 258 0071 (US)

+44 2035 002 764 (UK)

Email: [email protected]

Website: https://www.marketresearchfuture.com